Among patients with early-stage, non–screen-detected HCC, those with incidental detection had a reduced HR for mortality compared with those with symptomatic presentation, but this difference did not reach statistical significance (HR, 0.84; 95% CI, 0.57-1.22).
← all excerpts
Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients.
1
—
—